Lipocalin-2 (LCN2), a novel adipokine with catabolic activities in OA joints, contributes to the obesity and OA pathologies and is associated with other OA risk factors. The gene discussed is LCN2; the disease is obesity due to melanocortin 4 receptor deficiency.